CTI BioPharma's (CTIC) Pacritinib Placed on Full Clinical Hold; NDA Withdrawn
Tweet Send to a Friend
CTI BioPharma Corp. (CTI BioPharma) (Nasdaq: CTIC) provided an update regarding the clinical studies being conducted under the Company's Investigational ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE